Marc Buyse holds degrees from Brussels University (Belgium), Cranfield University (UK) and a ScD in biostatistics from the Harvard School of Public Health (USA). Prior to founding the International Drug Development Institute (IDDI) in 1991, he had worked at the European Organization for Research and Treatment of Cancer (EORTC) in Brussels and at the Dana Farber Cancer Institute in Boston. He is also the founder of CluePoints, a company dedicated to statistical monitoring of clinical trials, and an Associate Professor of biostatistics at Hasselt University in Belgium. His recent work focuses primarily on developing statistical methods for personalized medicine. (http://publicationslist.org/marc.buyse).